David Rescott

Stock Analyst at Baird

(3.59)
# 791
Out of 5,172 analysts
81
Total ratings
56.45%
Success rate
4.38%
Average return

Stocks Rated by David Rescott

PROCEPT BioRobotics
Mar 6, 2026
Initiates: Neutral
Price Target: $30
Current: $25.79
Upside: +16.32%
Medtronic
Feb 18, 2026
Maintains: Neutral
Price Target: $103$100
Current: $86.16
Upside: +16.06%
Boston Scientific
Feb 5, 2026
Maintains: Outperform
Price Target: $118$101
Current: $69.48
Upside: +45.37%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $345$374
Current: $335.85
Upside: +11.36%
SI-BONE
Dec 18, 2025
Maintains: Buy
Price Target: $21$23
Current: $12.79
Upside: +79.83%
Edwards Lifesciences
Dec 16, 2025
Maintains: Neutral
Price Target: $88$87
Current: $82.50
Upside: +5.45%
Haemonetics
Dec 15, 2025
Maintains: Outperform
Price Target: $87$99
Current: $58.58
Upside: +69.00%
LivaNova
Nov 13, 2025
Maintains: Outperform
Price Target: $63$70
Current: $62.19
Upside: +12.56%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111$110
Current: $66.71
Upside: +64.89%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600$575
Current: $477.97
Upside: +20.30%